Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies
about
sameAs
Review of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker?Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published StudiesEnteric coating can lead to reduced antiplatelet effect of low-dose acetylsalicylic acidGuidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapyPrevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirinProton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo-controlled trialTreatment and prevention of aspirin-induced gastroduodenal ulcers and gastrointestinal bleedingTriflusal: an antiplatelet drug with a neuroprotective effect?Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk?Cardioprotective aspirin users and their excess risk of upper gastrointestinal complicationsDose of aspirin in the treatment and prevention of cardiovascular disease: current and future directionsMy health: whose responsibility? Low-dose aspirin and older peopleOptimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors?Antioxidant and anti-inflammatory agents mitigate pathology in a mouse model of pseudoachondroplasiaA prospective study of aspirin use and the risk of gastrointestinal bleeding in menAnalgesic Medicine Utilization in Older People in New Zealand from 2005 to 2013Screening and treating Helicobacter pylori infection for gastric cancer prevention on the population level.Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction.Incidence of hemorrhagic stroke in the general population: validation of data from The Health Improvement Network.Interobserver variation in the endoscopic diagnosis of gastroduodenal ulcer scars: implications for clinical management of NSAIDs users.Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC studyEffect of aspirin cessation before endoscopy in Japanese patients with low-dose-aspirin-associated gastroduodenal mucosal injuryRisk factors associated with uncomplicated peptic ulcer and changes in medication use after diagnosis.Development of a tool to improve the quality of decision making in atrial fibrillation.Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended eventRole of aspirin in cancer prevention.H(2)S-releasing aspirin protects against aspirin-induced gastric injury via reducing oxidative stress.Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.Antiplatelet combinations for prevention of atherothrombotic eventsAspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.Low-dose aspirin-associated upper gastric and duodenal ulcers in Japanese patients with no previous history of peptic ulcers.Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes.Gastrointestinal side effects of drugs.Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesOral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options.Investigation of Gastroduodenal Mucosal Injury in Japanese Asymptomatic Antiplatelet Drug UsersApproach to managing musculoskeletal pain: acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs?Systematic Review and Meta-Analysis of Randomised Trials to Ascertain Fatal Gastrointestinal Bleeding Events Attributable to Preventive Low-Dose Aspirin: No Evidence of Increased Risk.Characteristics of hemorrhagic peptic ulcers in patients receiving antithrombotic/nonsteroidal antiinflammatory drug therapyUpper gastrointestinal complications among users of paracetamol.
P2860
Q22241777-4E4EA4D7-CEE6-4D35-BF6A-6605D428DFF5Q26751511-B5EEFC8F-8960-482F-88BF-2C856E9A6BE2Q27015913-A9D6A328-9C02-4A7C-8E77-AAF9EB8F8F71Q28166768-52AA2ADF-AA37-4E36-B45D-7E5E0438DC1FQ28192701-2D0F0CE3-984E-4222-AD98-B5EF79BACAC0Q28196664-15AF4B26-98F5-4486-8FE2-A703C1334024Q28198718-4111689F-3F7B-4DF9-B398-F32B64CD2EB0Q28200341-17BFF31F-1F58-447B-8D8A-8D048B7403DDQ28200403-1BEEDCEF-B75B-4675-B367-2FD1C86F65EFQ28200511-B30095C5-2C5C-4755-8CC5-6756EFC4C9D5Q28200895-36439F5D-ED34-4A6B-806C-A339A2B37F3AQ28201631-4CCCE4B2-4625-439B-8271-DF2FB47BB6C6Q28218738-D2DB3D6E-F1E6-4394-84E3-D4EBDCDAC3F5Q28648075-5D1CC293-E71C-40D9-8DB7-94C0BE78F90CQ28743884-4034414F-CE79-4BE0-A471-44E816BC4C85Q28833207-888CD430-9C85-402F-8F56-982222D81334Q30239019-D676A4E4-98A4-49BA-A7FE-2BA20BFB56AAQ30481799-7A86C502-6072-4BF1-8A6C-528A2A0FC224Q30581056-7413CC1B-9A4A-4A3A-B914-FAE5F7FA24E1Q31034785-33D85C49-98C4-4A3D-99F6-9450F358A503Q33605890-F17351D9-DA00-4569-8DFF-0545F46F659FQ33695564-C27B48A7-9808-42C9-8E1A-78ED1846ACB5Q33864188-C5EEE30B-4A46-4F38-9745-57483C1FDC86Q34041787-85727C66-4D07-4E40-9AF9-D99C9EF5FB4CQ34254787-2A64410E-88A8-4C6B-8AC0-5C7A877D0F09Q34376832-659A2425-DEB8-46F0-B7EE-F45DC8FCADEAQ34431045-EBB9F794-C398-4EFF-918A-F0B9CC611C0DQ34536091-03B63374-C1F1-4D65-AA27-1A1DE274BC8FQ34566264-6A280B12-1413-4E31-80A9-6BFE5DDE9C74Q34771381-A603C1BB-D29D-4185-8EBD-AFA3F337565BQ35038558-0D1E3151-B7C5-4037-84D4-E557A7B64A76Q35117393-ADE9536F-0A5D-4D40-9316-FBF84F4326ACQ35194370-8D27557F-E712-4C3F-8039-10102B792684Q35752619-AE7BD908-8C04-4062-B8AF-54821A0789EBQ35797491-B51A3215-ABB8-4BC4-ABDA-CF8371711DCDQ35857875-6D9C3A9D-94BF-481C-84B6-D902C63AEF5BQ35942177-E440B354-15C9-4172-A0B3-DFEE50008CFFQ36192713-B3AD44F7-3577-4655-AD4E-E247FA931604Q36385154-E15BDC7B-C5D9-433D-8276-DE393EC9C223Q36447530-1120DBD6-7B18-497D-96EA-D2212D16273C
P2860
Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Association between aspirin an ...... eview of epidemiologic studies
@ast
Association between aspirin an ...... eview of epidemiologic studies
@en
Association between aspirin an ...... eview of epidemiologic studies
@nl
type
label
Association between aspirin an ...... eview of epidemiologic studies
@ast
Association between aspirin an ...... eview of epidemiologic studies
@en
Association between aspirin an ...... eview of epidemiologic studies
@nl
prefLabel
Association between aspirin an ...... eview of epidemiologic studies
@ast
Association between aspirin an ...... eview of epidemiologic studies
@en
Association between aspirin an ...... eview of epidemiologic studies
@nl
P2093
P2860
P31
P3181
P1476
Association between aspirin an ...... eview of epidemiologic studies
@en
P2093
F J de Abajo
L A García Rodríguez
S Hernández-Díaz
P2860
P304
P3181
P356
10.1046/J.0306-5251.2001.01476.X
P407
P577
2001-11-01T00:00:00Z